NUVB - Nuvation Bio Inc. -  [ ]

Ticker Details
Nuvation Bio Inc.
IPO Date: August 24, 2020
Sector: Healthcare
Industry: Biotech
Market Cap: $1.64B
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.14 | 3.26%
Avg Daily Range (30 D): $0.13 | 2.84%
Avg Daily Range (90 D): $0.14 | 2.77%
Institutional Daily Volume
Avg Daily Volume: 1.76M
Avg Daily Volume (30 D): 3.85M
Avg Daily Volume (90 D): 4.16M
Trade Size
Avg Trade Size (Sh.): 208
Avg Trade Size (Sh.) (30 D): 177
Avg Trade Size (Sh.) (90 D): 173
Institutional Trades
Total Institutional Trades: 841
Avg Institutional Trade: $2.18M
Avg Institutional Trade (30 D): $1.47M
Avg Institutional Trade (90 D): $1.8M
Avg Institutional Trade Volume: .46M
Avg Institutional Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $2.65M
Avg Closing Trade (30 D): $1.47M
Avg Closing Trade (90 D): $2.04M
Avg Closing Volume: 513.86K
 
News
Apr 13, 2026 @ 4:04 AM
Insider Sells 200K Shares of Biotech Company Nuvat...
Source: Pamela Kock
Mar 21, 2026 @ 9:15 PM
NUVB Investors Have Opportunity to Join Nuvation B...
Source: Schall Law Firm
Mar 10, 2026 @ 7:52 PM
INVESTOR ALERT: Pomerantz Law Firm Reminds Investo...
Source: Pomerantz Llp
Feb 17, 2026 @ 4:17 PM
New Treatment Modalities Are Reaching Cancers That...
Source: Prnewswire
Nov 3, 2025 @ 11:10 AM
Nuvation Bio Chief Scientist Sells 100,000 Shares ...
Source: Jonathan Ponciano
Financials
  TTM Q1 2026 Q4 2025
Basic EPS $-.42 $.02 $-.11
Diluted EPS $-.43 $.01 $-.11
Revenue $143.05M $83.23M $41.87M
Gross Profit
Net Income / Loss $-145.99M $5.4M $-36.59M
Operating Income / Loss $-150.18M $3.88M $-34.04M
Cost of Revenue
Net Cash Flow $77.41M $-38.7M $65.19M
PE Ratio